Rankings
▼
Calendar
CGEN Q2 2024 Earnings — Compugen Ltd. Revenue & Financial Results | Market Cap Arena
CGEN
Compugen Ltd.
$202M
Q2 2024 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$7M
Gross Profit
$5M
76.8% margin
Operating Income
-$3M
-50.9% margin
Net Income
-$2M
-31.7% margin
EPS (Diluted)
$-0.02
QoQ Revenue Growth
+161.9%
Balance Sheet
Total Assets
$110M
Total Liabilities
$52M
Stockholders' Equity
$58M
Cash & Equivalents
$12M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$7M
$0
—
Gross Profit
$5M
$0
—
Operating Income
-$3M
-$10M
+66.6%
Net Income
-$2M
-$9M
+77.1%
← FY 2024
All Quarters
Q3 2024 →